glp 1 and heart failure Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent Independent Drivers of Therapeutic Benefit GLP-1 and the cardiovascular system

To read more in detail (and explore the research further):

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

This article reveals whether moringa powder can help you lose weight and provides information on other potential benefits, various forms, and safety.

04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Nooms leading GL